Bonum Therapeutics, Inc. — Form D
Bonum Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-29. The offering totals $93.0M, of which $45.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-29
- Form: D
- Accession: 0001898714-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $93.0M
- Amount sold: $45.0M
- Remaining: $48.0M
- Investors: 10
- Date of first sale: 2022-11-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-465970
Issuer
- Name: Bonum Therapeutics, Inc.
- CIK: 0001898714
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1150 EASTLAKE AVENUE E SUITE 1100, SEATTLE, WA, 98109
- Phone: 206-888-8485
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Samuel Bjork | Director | Cambridge, MA |
| Karl Handelsman | Director | Grand Prairie, TX |
| John McKearn | Director | Seattle, WA |
| John Mulligan | Director | Seattle, WA |
| Mitchell Mutz | Director | Seattle, WA |
| Monique Schiersing | Director | Seattle, WA |
| Nicholas Walrod | Director | Minneapolis, MN |
| Diane Hollenbaugh | Executive Officer | Seattle, WA |
| John Mulligan | Executive Officer | Seattle, WA |
| Neela Patel | Executive Officer | Seattle, WA |
| John Mulligan | Promoter | Seattle, WA |
| Gaurav Aggarwal | Related Person | Palo Alto, CA |
| Karl Handelsman | Related Person | Grand Prairie, TX |
| Nicholas Walrod | Related Person | Minneapolis, MN |
| Samuel Bjork | Related Person | Cambridge, MA |
| Mitchell Mutz | Related Person | Seattle, WA |
| Diane Hollenbaugh | Related Person | Seattle, WA |
| John Mulligan | Related Person | Seattle, WA |
| Monique Schiersing | Related Person | Seattle, WA |
| John McKearn | Related Person | Seattle, WA |
| Neela Patel | Related Person | Seattle, WA |
| Samuel Blackman | Related Person | Seattle, WA |
Other filings by this issuer (2)
More